Harbor Clinical

Harbor Clinical is a privately held, global CRO that combines a proprietary software platform with traditional clinical trial services to offer integrated support for biopharma clients. Founded in 2017, the company has established operational hubs in key life sciences regions including Boston, Sofia, and Hyderabad to deliver cost-effective, scalable research solutions. Its model targets the growing demand for tech-enabled CRO services, particularly in complex therapeutic areas within diagnostics and digital health. As a service provider, its financial position is tied to client contracts and project pipelines rather than a therapeutic pipeline of its own.

A suite of integrated software solutions for clinical trial management, data capture, and operational support, designed to enhance efficiency and data quality in clinical research, particularly for diagnostics and digital health trials.

Harbor Clinical competes in the crowded global CRO market against giants like IQVIA, Labcorp, and ICON, as well as numerous mid-sized and niche CROs. Its differentiation is based on a combined tech platform and service model focused specifically on the complex diagnostics and digital health sectors, where larger players may be less agile.